HE phenomenon of ischemic tolerance has engendered widespread interest because it provides insight into the mechanism that underlies endogenous neuroprotection. 10 This phenomenon can occur secondary to both global and focal cerebral ischemia. Prior exposure to brief episodes of ischemia not only protects CA1 neurons from the subsequent severe injury sustained in global cerebral ischemia, 24, 25 but also attenuates the infarct size seen in focal cerebral ischemia. 9, 44 Preconditioning, prior exposure to sublethal environmental stress, is not limited to brief ischemia. A cellular stress response that eventually protects brain tissue can also be induced by an incidence of noxious stress that is different in nature from the subsequent lethal stress (cross-tolerance 23 Preconditioning with LPS has been known to reduce infarct size resulting from experimental myocardial ischemia. 6, 42 In the brain, researchers have previously demonstrated that preconditioning with LPS resulted in an approximate 26 to 31% reduction in infarct volume, and the neuroprotective effect is obvious 2 to 4 days later, with a maximum effect at 3 days. 13, 46 Although the exact mechanisms underlying LPS preconditioning in the brain have not been fully elucidated, one of the potential candidates important in developing tolerance is thought to be TNF␣. The administration of a neutralizing antibody against TNF (TNF-binding protein) nullified the effect of attenuation of infarct volume in the LPS-induced tolerant state. 46 The downstream signaling involved in such neuroprotective processes could be triggered by TNF␣, including upregulation of eNOS, 20,39,41 ceramide, 52 and superoxide dismutase expression. 
in focal cerebral ischemia, tolerance produced by other preconditioning stimuli has been shown to produce persistent protection, lasting a week or more. In the absence of longerterm observation, however, whether the attenuation of infarct volume induced by preconditioning is merely a reflection of a delay in the cell death process remains to be fully determined. Second, postischemic lCBF disturbances such as hypoperfusion have been implicated in the pathogenesis of brain injury. 21 Although the protective effect of ischemic preconditioning was not relevant to blood flow, 3, 9, 28 whether cross-tolerance exerts a protective effect via alterations in lCBF remains uncertain.
In the present study, we used MR imaging to investigate an LPS-induced cross-tolerance model to determine the following. 1) Does preconditioning with LPS offer a long-term beneficial effect by reducing lesion size? 2) Does an LPSinduced tolerant state demonstrate a different lesion volume evolution compared with the nontolerant state? We also measured lCBF for a longer duration than has been previously reported to determine whether preconditioning with LPS provides an inhibitory effect on reduction of lCBF after MCA occlusion. Endothelial nitric oxide synthase expression in the periinfarct area was also detected and studied because it could be relevant to lCBF alteration.
Materials and Methods

Animal Preparation
Adult male spontaneously hypertensive rats, weighing 280 to 320 g each, were obtained from Charles River (Tokyo, Japan). All procedures involving the animals were performed in strict accordance with the NIH Guidelines for the Care and Use of Laboratory Animals and were approved by the local Animal Care and Use Committee at the University of Tokyo.
Preconditioning With LPS
Lipopolysaccharide (Escherichia coli 0111:B4 phenol extract; Sigma Chemical Co., St. Louis, MO) was dissolved in 0.3 ml of sterile, pyrogen-free physiological saline and administered to rats via the femoral vein at a dose of 0.9 mg/kg of body weight 72 hours prior to induction of focal cerebral ischemia. 46 Control animals received the same amount of saline via the same route.
Focal Cerebral Ischemia
Seventy-two hours after LPS or saline administration, spontaneously hypertensive rats were anesthetized with halothane (4% induction, 2% maintenance) in N 2 O/O 2 (7:3 vol/vol) through a facemask. Focal cerebral ischemia was induced by tandem occlusion of the left MCA and the ipsilateral CCA, as described previously. 5 Briefly, the distal segment of the MCA crossing over the rhinal fissure was electrocauterized and transected; this was followed immediately by ligation and transection of the left CCA. The rectal and temporal muscle temperatures were maintained at 37 Ϯ 0.5˚C during all surgical procedures and during the animals' recovery from anesthesia (that is, until normal locomotor activity was observed). As part of the preliminary study, blood pressure was monitored via an indwelling arterial catheter and serial blood gas level sampling was performed before and after MCA occlusion.
Magnetic Resonance Imaging Analysis
The six LPS-induced tolerant rats and the six nontolerant control rats were subjected to MR imaging evaluation 6 hours, 24 hours, 4 days, 7 days, and 14 days after MCA occlusion to investigate the lesion evolution. After the final series of MR images obtained at 14 days, the experiment was terminated; the animals were killed and their brains were removed for histopathological evaluation. Throughout the experiment, the rats' rectal temperature had been maintained at 37 Ϯ 0.5˚C by using a water-heated pad. The MR imaging was performed using a 7.05-tesla horizontal spectrometer (UNITY plus-SIS 300/183; Varian, Inc., Palo Alto, CA) equipped with an actively shielded gradient up to 120 mtesla/m per axis by using a 3.8-cm diameter quadrature coil. Serial T 2 -and diffusionweighted images were produced using the following parameters: 128 ϫ 128 matrices with a field of view of 40 ϫ 40 mm 2 , and nine contiguous and 2-mm-thick slices. In the T 2 relaxometric study, three images were acquired with echo times of 8, 60, and 100 msec (TR 3000 msec). In the diffusion study (TR 3000 msec, TE 60 msec), diffusion gradients (duration 24 msec; separation 32 msec) were applied in the z axis during both TE/2 processes. Gradients of 0, 23, and 32 mtesla/m were used, resulting in corresponding b-values of 0, 523, and 1013 seconds/mm 2 , respectively. Lesion areas were traced and volumes were calculated by integration of the areas on a digitized imaging system (NIH Image 1.62; NIH, Bethesda, MD), which was followed by correction for brain swelling as previously described. 45 
Morphometric Analysis of Infarct Volume
Following the final MR imaging studies at 14 days, the animals were deeply anesthetized and transcardially perfused with 4% paraformaldehyde. Perfusion-fixed brains were cut into 20-m coronal sections in a cryostat at 12 predefined serial levels (bregma 3.7 to Ϫ7.3 mm
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) and stained with cresyl violet. Volumetric assessment was conducted according to previously described methods. 45 The brain samples were randomly numbered to blind the researchers as to the experimental subgroup.
Measurement of CBF
The lCBF was monitored in the periinfarct area in a separate set of 16 animals by using LDF (ALF21, Advance Laser Flowmeter; Advance Co., Ltd., Tokyo, Japan) as described previously. 3 The distances measured on the MR image from the border of the damaged area to the midline between the level of the bregma Ϫ3.3 and Ϫ5.3 mm were significantly different between the LPS and control groups. Based on this result, the point 4.3 mm posterior and 3.5 mm lateral to the bregma on the ipsilateral side of the skull was defined as the periinfarct region in this model (Fig. 1) . The lCBF was determined just before, 15 minutes, 30 minutes, 6 hours, 24 hours, 4 days, 7 days, and 14 days after MCA occlusion for both groups. Extreme care was taken to position the LDF probe in exactly the same cortical location for each measurement. The skin was closed with sutures after each measurement. Ten lCBF readings obtained 2 seconds apart, as noted on the digital display of the LDF, were collected and averaged to provide a value for lCBF for each location. The initial lCBF recording was taken as 100% and subsequent flow changes were expressed relative to this value.
Western Blot Analysis
Brain samples (three from the LPS preconditioned group without ischemia and five from the LPS preconditioned group with ischemia) corresponding to the periinfarct regions from ipsilateral and contralateral hemispheres (bregma 3.7 to Ϫ7.3 mm, 3-5 mm lateral to the midline) were homogenized. For immunoblot analysis of proteins, samples from regions corresponding to the periinfarct regions in the ipsi-and contralateral regions were freshly excised. They were then homogenized at 4˚C in 20 mM HEPES-KOH (pH 7.4), 2 mM ethylenediaminetetraacetic acid (pH 8), 1% Triton X-100, 10% glycerol, 1 mM dithiothreitol, 50 mM ␤-glycerophosphate disodium salt, 1 mM phenylmethylsulfonate, 10 g/ml aprotinin, and 10 g/ml leupeptin and centrifuged at 15,000 G for 15 minutes to remove any insoluble material. The supernatant was retained. The protein concentration of the supernatant was determined using a BCA protein assay kit (Pierce Biotechnology, Inc., Rockford, IL) with bovine serum albumin as the standard. Solubilized proteins (20 g per lane) were subjected to 7.5% sodium dodecyl sulfate-polyacrylamide gel for eNOS, and then transferred to polyvinylidene fluoride membrane (Immobilon-P; Millipore Corp., Bedford, MA). The membrane was blocked with 5% nonfat skim milk in 0.1% Tris-buffered salineTween for 1 hour at room temperature and incubated with mouse anti-eNOS monoclonal antibody (1:2500 dilution) overnight at 4˚C. After washing in 0.1% Tris-buffered saline-Tween, the membrane was incubated with goat anti-mouse immunoglobulin G conjugated to horseradish peroxidase (1:1000) for 2 hours at room temperature. The horseradish peroxidase product was visualized using a chemiluminescence Western blot detection system (ECL; Amersham Biosciences, Buckinghamshire, United Kingdom) and captured by luminescent image analyzer system (LAS-1000 Plus; Fujifilm, Tokyo, Japan). Quantitative analysis was performed using NIH Image 1.62.
Statistical Analysis
Data are expressed as means Ϯ SDs and were analyzed using the Student t-test, linear regression analysis, or one-way ANOVA. Post hoc comparisons were performed using the Fisher protected least significant difference test after one-way ANOVA. Two-way ANOVA was used in the serial lCBF study. Post hoc comparisons were made with the Tukey test. Differences were considered significant at a probability value less than 0.05.
Results
The preliminary study demonstrated that physiological variables for the individual groups remained in the normal range before and after MCA occlusion (Table 1) . Based on this result, analysis of the physiological parameters was not incorporated into the experiment because repeated blood withdrawal is not suitable for survival experiments.
Preconditioning with a dose of 0.9 mg/kg of LPS attenuated infarct size assessed 24 hours following MCA occlusion compared with that of the control group (LPS, 16 Ϯ 2.1%; control, 27.9 Ϯ 1.8%; p Ͻ 0.01; eight animals in each group). Based on this result, the dose of LPS and the interval between preconditioning and the ischemic insult were determined to be 0.9 mg/kg and 72 hours.
Assessment With MR Imaging
Brain damage was initially observed on diffusionweighted imaging 6 hours after MCA occlusion (Fig. 2) . In contrast, T 2 -weighted MR imaging revealed slight hyperintensity in the ipsilateral cortex at the same time. Afterward, the signal intensity of the lesion gradually increased on T 2 -weighted imaging. Finally, a hyperintense lesion observed on both diffusion-and T 2 -weighted imaging appeared similar at 24 hours. At 7 days, the area of infarction was actually darker on the diffusion-weighted image, whereas the signal intensity of the lesion was slightly decreased but still recognizable on T 2 -weighted imaging. This finding is in agreement with a previous study in which it was demonstrated that diffusion-weighted imaging could not be used to quantify infarct volume observed on Day 7 because there was no uniform signal in the damaged area. 15 It was also apparent that the damaged area is mainly localized in the brain cortex.
Preconditioning with LPS achieved a significant reduction in lesion size (%) at all time points examined within 14 days after MCA occlusion, indicating that lesion evolution was largely different between the two groups (6 hours: LPS 22. (Fig. 3A and B) .
Histopathological Assessment
To ensure an accurate assessment of lesion size derived from T 2 -weighted imaging, a correlation of the infarct size, as determined by histopathological assessment, and the T 2 -weighted imaging method was confirmed at 14 days. The damaged area in the cresyl violet-stained sections from the LPS and the control animals significantly correlated with the hyperintense area on T 2 -weighted imaging (14 days: y = 0.84x ϩ 2.71, r = 0.95, p Ͻ 0.05) (Fig. 3C) . The LPS-preconditioned rats exhibited smaller volumes (p Ͻ 0.01) of ischemic damage (20.1 Ϯ 2.2%) than those seen in control rats (28.4 Ϯ 4%).
Assessment of CBF
The lCBF was markedly reduced in both groups at 15 minutes following MCA occlusion (36.3 Ϯ 10.1% in the control group and 31.7 Ϯ 12.8% in the LPS group; five animals in each group) (Fig. 4) . There was a trend toward a gradual increase in the average lCBF in the LPS group 6 hours after MCA occlusion compared with that in the control group. The preconditioning main effect was significant (p Ͻ 0.05). The animals preconditioned with LPS showed a significant inhibition of lCBF reduction in the periinfarct area compared with the control animals at all time points.
Western Blot Analysis
Enhanced expression of eNOS was observed from 24 to 72 hours after LPS preconditioning. In LPS-pretreated rats, expression of eNOS in the periinfarct regions increased 6 hours after MCA occlusion and peaked at 24 hours. This pattern was similar to that seen in control rats. Although eNOS expression returned to normal levels 4 days after MCA occlusion in the control group, the LPS preconditioning group exhibited higher levels up to 14 days after MCA occlusion (Fig. 5) .
Discussion
In the present study, we use MR imaging to demonstrate that preconditioning with LPS leads to attenuation of lesion size as many as 14 days after MCA occlusion. In addition, we elucidate the different features of lesion evolution that are seen between tolerant and nontolerant rats subjected to MCA occlusion. Our studies also show that preconditioning with LPS inhibits reduction of lCBF in the periinfarct area.
Clarification of Differences in Infarct Evolution
Because there have been only a few reports in which the temporal evolution of infarction in the preconditioned brain has been characterized, it remains unclear how preconditioning modifies infarct evolution in the tolerant state. To date, there have been few published reports in which the effects of preconditioning on reducing infarct size have been examined when survival times longer than 72 hours after ischemia have been included. 9, 32, 34 Attenuation of efficacy of neuroprotection over time has also been reported. Significant preservation of CA1 neurons has been observed at 10 
FIG. 3.
Graphs showing the effect of LPS preconditioning on lesion evolution in the same rat brains. Lesion volumes were assessed at 6 hours and 24 hours based on diffusion-weighted imaging (A) and at 4, 7, and 14 days based on T 2 -weighted imaging (B) after MCA occlusion. Significant reduction of lesion volume was initially evident 6 hours after the MCA occlusion and sustained during all the time points examined (mean Ϯ SD, *p Ͻ 0.05 and **p Ͻ 0.01 when compared with the control group; six rats in each group, unpaired Student t-test). C: Correlation between T 2 -weighted imaging-estimated lesion volume and histologically assessed infarct volume 14 days after MCA occlusion. A slope of 0.84 with a correlation coefficient of 0.95 was obtained at 14 days, demonstrating a significant correlation between the two measurements (p Ͻ 0.05, six rats in each group, determined by linear regression analysis with Fisher protected least significant difference test). days in preconditioned animals, but there was a significant decline at 30 days. 12 In contrast to preconditioning, postischemic hypothermia (30˚C for 3 hours) 14 and administration of several pharmacological agents only delayed rather than prevented ischemic cell death. 35, 48 Magnetic resonance imaging can be used to help evaluate the long-term effect of neuroprotection in the same animal. 2 Present diffusion-and T 2 -weighted imaging data provided us with a very effective means for dynamically assessing lesion evolution in LPS-preconditioned rats after MCA occlusion. Clinically, diffusion-weighted imaging has recently generated great interest because of its ability to disclose several clinical conditions, such as early pathophysiological changes in acute stroke, within a few minutes after an arrest of blood flow. 31 In animal models of stroke, diffusionweighted imaging allows detection of cerebral ischemia within a few minutes of onset. 8, 17 This capacity appears to be analogous in humans, in whom bright lesions detected on diffusion-weighted imaging have been documented as early as 39 minutes after stroke onset. 51 In experimental focal ischemia, the degree of ADC reduction has been reported to depend on both anatomical location and duration of ischemia. 30, 40 Provided that the duration of ischemia is short enough, maximal decrease in the ADC and impaired energy metabolism are even reversible after reperfusion. If ischemia is prolonged, the ADC may not be restored fully, depending on the duration of ischemia and the value of the ADC immediately before reperfusion. 16 Because the duration and severity of ischemia is thought to be strong in our model, hyperintense areas found 6 hours after MCA occlusion on diffusion-weighted images in our model are thought to be ischemic lesions.
Hyperintense lesions, however, are not always associated with low ADC values, because both ADC and T 2 affect signal intensity on diffusion-weighted imaging. The elongated T 2 effect can become dominant, and these lesions can then appear bright on diffusion-weighted imaging despite normal or even elevated diffusion (T 2 shine-through). 7 For these reasons, we interpreted diffusion-weighted imaging with T 2 -weighted imaging. Three days after the ischemic insult, the hyperintensity characterizing an ischemic lesion on diffusion-weighted imaging is often reduced. 1, 19 Therefore, we performed diffusion-weighted imaging for lesion size assessment 6 and 24 hours after MCA occlusion and T 2 -weighted imaging on Days 4, 7, and 14. The size of the initial diffusion-weighted image abnormality or initial ADC abnormality correlates well with clinical outcome and size of the chronic lesion volume measured on follow-up T 2 -weighted images. 49 We found that lesion volumes in the LPS group were significantly smaller than those in the control group at all of the time points examined. We conclude that preconditioning with LPS does not merely delay but actually prevents ischemic cell death given that a reduction in lesion size was sustained for as many as 14 days after MCA occlusion. To our knowledge, this is the first report to provide direct evidence that preconditioning with LPS may exert consistent resistance to focal cerebral ischemia up to the chronic phase. Our results demonstrate that the augmentation of lesion volume was evident between 24 hours and 4 days in the control group. Afterward, there was a trend toward attenuated lesion volume to the level noted at 6 hours. It is likely that the percentage of lesion size in the LPS group reached a plateau 6 hours after MCA occlusion and displayed no significant changes thereafter.
Correlation of LPS Preconditioning, CBF, and eNOS Expression
It has been reported that intracerebroventricular administration of LPS at a dose of 1 mg/kg produces a progressive increase in lCBF 1 to 4 hours after administration. 37 The lCBF measurements performed in our study were targeted at the reversibly damaged tissue of the lesioned cortex (the periinfarct area). Preconditioning with LPS inhibited the reduction of lCBF in the periinfarct area of the evolving infarcts, which may account for the attenuation of infarct size. The lCBF did not differ significantly between the LPS and control groups, as determined by autoradiography 15 minutes after MCA occlusion. 13 This was confirmed in our study because lCBF in the periinfarct area was on average almost the same between the two groups within 30 minutes of MCA occlusion; however, in our longer-term investigation, the reduction of lCBF during infarct evolution was inhibited significantly in the LPS group compared with the control group. This result was supported by the finding that LPS elicits an increased expression of eNOS in blood vessels after permanent focal cerebral ischemia. 41 In the brain, three isoforms of NOS, namely neuronal NOS (nNOS, NOS1), inducible NOS (iNOS, NOS2), and endothelial NOS (eNOS, NOS3), have been implicated in biological roles such as neurotransmission, neurotoxicity, immune function, and blood vessel regulation, with each isoform exhibiting some overlapping roles. Authors of previous studies have shown that iNOS is induced in the brain by systemic treatment with LPS. Induction of eNOS in response to a low dose of LPS, together with its localization in major components of the blood-brain barrier, suggests that brain eNOS is involved in an early pathophysiological response against systemic infection before iNOS is induced with progression of the infection. 18 Lipopolysaccharide increases phosphorylation of Akt/protein kinase B (Akt), a key enzyme regulating proliferation, apoptosis, and inflammation. Activated Akt phosphorylates eNOS and subsequently increases NOS activity. 20 Endothelial NOS mediates LPSstimulated TNF␣ expression through the cAMP/cAMPdependent protein kinase-dependent p38 mitogen-activated protein kinase pathway. 39 Preservation of eNOS activity in the cerebral vasculature, particularly in the ischemic penumbra, is thought to be especially important in preserving blood flow 27 and limiting neurological loss. 43 Because the periinfarct area is the reversibly damaged tissue of the lesioned cortex, we hypothesized that eNOS expression is upregulated in the periinfarct area, which may account for the attenuation of infarct size. Thus, eNOS-mediated flow-dependent mechanisms may contribute to neuroprotection in the LPS-preconditioned rats. Further study is required to clarify the effect of preconditioning with LPS on the alteration of lCBF in the periinfarct area.
Conclusions
We have demonstrated that preconditioning with LPS provides resistance to focal cerebral ischemia and that this protection is initially evident, as revealed by diffusion-and Enhanced expression of eNOS in response to LPS preconditioning was observed from 24 hours to 72 hours later. B and C: Western blot and bar graph showing expression of eNOS after MCA occlusion with either LPS preconditioning or saline control, five rats in each group. Samples were obtained from the periinfarct regions and the corresponding regions of the contralateral hemisphere (bregma 3.7 to Ϫ7.3 mm, 3 to 5 mm lateral to the midline). In LPS-pretreated rats, expression of eNOS in the periinfarct regions significantly increased 6 hours after MCA occlusion and peaked at 24 hours (*p Ͻ 0.05). The LPS group exhibited sustained higher expression of eNOS as many as 14 days after MCA occlusion (**p Ͻ 0.01 when compared with the control group, five rats in each group, unpaired Student t-test). Blots were also probed for ␤-actin as a housekeeping gene product.
T 2 -weighted imaging 6 hours after ischemic onset. This beneficial effect is sustained for up to 14 days after the initial insult. Preconditioning with LPS inhibited augmentation of the ischemic lesion and inhibited reduction of lCBF in the periinfarct area. Sustained upregulation of eNOS in the periinfarct area could be a possible candidate for preservation of lCBF, leading to reduction of infarct size in the LPS-induced tolerant state.
